Home/Filings/4/0001358403-18-000006
4//SEC Filing

Musso Alan A 4

Accession 0001358403-18-000006

CIK 0001358403other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:01 PM ET

Size

7.8 KB

Accession

0001358403-18-000006

Insider Transaction Report

Form 4
Period: 2018-01-02
Musso Alan A
CFO and Treasurer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-01-02+22,50022,500 total
    Exercise: $9.23Exp: 2028-01-01Common Stock (22,500 underlying)
  • Award

    Restricted Stock Units

    2018-01-02+12,50012,500 total
    Common Stock (12,500 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on January 2, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of BLCM common stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning January 2, 2019.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001295830

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:01 PM ET
Size
7.8 KB